West Virginia Senate Bill SB150

West Virginia 2022 Regular Session

• Introduced: 1/12/22
• Refer: 1/12/22

Caption

Requiring wholesale drug distributors to report certain information to WV Board of Pharmacy

Impact

The enactment of SB150 would significantly enhance the accountability of wholesale drug distributors within West Virginia. This reporting requirement is expected to assist in monitoring the distribution of controlled substances more effectively, potentially reducing the risk of misuse and illegal distribution. The bill’s requirement for electronic submission aims to streamline the reporting process, thereby improving data accuracy and availability for state regulatory monitoring.

Summary

Senate Bill 150, introduced in the West Virginia Legislature, aims to mandate wholesale drug distributors to report specific information regarding drug sales to the West Virginia Board of Pharmacy. The bill requires these distributors to submit details such as the purchaser's identification, drug identification, quantity sold, date of sale, and the distributor's license number. By enforcing electronic reporting protocols, SB150 seeks to improve oversight in the pharmaceutical distribution process, particularly concerning controlled substances.

Sentiment

The sentiment surrounding SB150 appears to be supportive among public health advocates and regulatory bodies, who see it as a crucial step toward addressing concerns related to prescription drug abuse and ensuring public safety. However, there may be logistical concerns from wholesale drug distributors about the administrative burden and costs associated with compliance, which could lead to disagreements about the implementation of such requirements.

Contention

One notable point of contention related to SB150 is the balance between regulatory oversight and the operational realities faced by wholesale distributors. While proponents argue that robust reporting will lead to better drug oversight and public health outcomes, opponents may question the feasibility of the stringent reporting requirements and whether they could impose additional costs on businesses. Additionally, the potential for electronic reporting failures presents a concern, as the bill includes provisions for waivers, possibly complicating compliance for distributors facing technical issues.